Published in Infect Immun on September 01, 1991
Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev (2005) 5.69
Clostridium difficile: clinical disease and diagnosis. Clin Microbiol Rev (1993) 2.19
Evidence for a modular structure of the homologous repetitive C-terminal carbohydrate-binding sites of Clostridium difficile toxins and Streptococcus mutans glucosyltransferases. J Bacteriol (1992) 1.80
Experimental immunization of rats with a Streptococcus mutans 59-kilodalton glucan-binding protein protects against dental caries. Infect Immun (1996) 1.40
Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live, attenuated Vibrio cholerae vector strain. Infect Immun (1997) 1.34
Antigenicity and immunogenicity of a synthetic peptide derived from a glucan-binding domain of mutans streptococcal glucosyltransferase. Infect Immun (1993) 1.30
Immunization of rats with synthetic peptide constructs from the glucan-binding or catalytic region of mutans streptococcal glucosyltransferase protects against dental caries. Infect Immun (1995) 1.26
Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A. Infect Immun (1999) 1.20
UpaH is a newly identified autotransporter protein that contributes to biofilm formation and bladder colonization by uropathogenic Escherichia coli CFT073. Infect Immun (2010) 1.13
Local and systemic neutralizing antibody responses induced by intranasal immunization with the nontoxic binding domain of toxin A from Clostridium difficile. Infect Immun (1999) 1.09
Conserved repeat motifs and glucan binding by glucansucrases of oral streptococci and Leuconostoc mesenteroides. J Bacteriol (2004) 0.91
Protective antibody responses against Clostridium difficile elicited by a DNA vaccine expressing the enzymatic domain of toxin B. Hum Vaccin Immunother (2012) 0.84
Structural and antigenic characteristics of Streptococcus sobrinus glucan binding proteins. Infect Immun (1998) 0.83
C-terminal repeats of Clostridium difficile toxin A induce production of chemokine and adhesion molecules in endothelial cells and promote migration of leukocytes. Infect Immun (2007) 0.81
Biochemical and Immunological Characterization of Truncated Fragments of the Receptor-Binding Domains of C. difficile Toxin A. PLoS One (2015) 0.77
New approaches in oral microbiology. J R Soc Med (1994) 0.75
Clostridium difficile: its disease and toxins. Clin Microbiol Rev (1988) 7.26
Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun (1985) 5.44
Molecular characterization of the Clostridium difficile toxin A gene. Infect Immun (1990) 4.06
Production of Clostridium difficile antitoxin. Infect Immun (1980) 3.95
Nucleotide sequence of a glucosyltransferase gene from Streptococcus sobrinus MFe28. J Bacteriol (1987) 3.40
A family of clostridial and streptococcal ligand-binding proteins with conserved C-terminal repeat sequences. Mol Microbiol (1991) 2.62
Carbohydrate-binding proteins: tertiary structures and protein-sugar interactions. Annu Rev Biochem (1986) 2.61
Sequence analysis of the gene for the glucan-binding protein of Streptococcus mutans Ingbritt. Infect Immun (1990) 2.55
Immunoblotting to demonstrate antigenic and immunogenic differences among nine standard strains of Clostridium difficile. J Clin Microbiol (1986) 1.73
Toxin A of Clostridium difficile is a potent cytotoxin. J Clin Microbiol (1990) 1.65
Toxin A of Clostridium difficile binds to the human carbohydrate antigens I, X, and Y. Infect Immun (1991) 1.44
Association between production of toxins A and B and types of Clostridium difficile. J Clin Pathol (1987) 1.38
Molecular cloning and expression of Clostridium difficile toxin A in Escherichia coli K12. FEBS Lett (1987) 1.22
Mapping of linear B-cell epitopes of the S2 subunit of pertussis toxin. Infect Immun (1989) 1.13
Molecular genetics of glucan metabolism in oral streptococci. Arch Oral Biol (1990) 1.09
Identification of toxigenic Clostridium difficile strains by using a toxin A gene-specific probe. J Clin Microbiol (1990) 1.04
Nucleotide sequence of Clostridium difficile toxin A gene fragment and detection of toxigenic strains by polymerase chain reaction. FEMS Microbiol Lett (1990) 0.98
Solid-phase peptide synthesis. Methods Enzymol (1977) 0.88
Sensitive detection of Helicobacter pylori by using polymerase chain reaction. J Clin Microbiol (1992) 3.97
Lipoproteins of gram-positive bacteria. J Bacteriol (1995) 3.83
Wall-associated protein antigens of Streptococcus mutans. J Gen Microbiol (1979) 3.62
Nucleotide sequence of a glucosyltransferase gene from Streptococcus sobrinus MFe28. J Bacteriol (1987) 3.40
Typing scheme for Clostridium difficile: its application in clinical and epidemiological studies. Lancet (1984) 2.87
Molecular cloning and expression of Campylobacter pylori species-specific antigens in Escherichia coli K-12. Infect Immun (1989) 2.81
Diagnostic efficiency of an ultrarapid endoscopy room test for Helicobacter pylori. Gut (1991) 2.64
The epidemiology of Clostridium difficile with use of a typing scheme: nosocomial acquisition and cross-infection among immunocompromised patients. J Infect Dis (1986) 2.61
Sequence analysis of the gene for the glucan-binding protein of Streptococcus mutans Ingbritt. Infect Immun (1990) 2.55
Nucleotide sequence of two genes from Helicobacter pylori encoding for urease subunits. Nucleic Acids Res (1990) 2.38
Bile-salt deconjugation and steatorrhoea in patients with the stagnant-loop syndrome. Lancet (1968) 2.36
Detection of pathogenic Yersinia enterocolitica by the polymerase chain reaction. Lancet (1990) 2.23
Restorative proctocolectomy with ileal reservoir: a pathophysiological assessment. Gut (1981) 2.21
Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats. Diabetes (2001) 2.10
Molecular, immunological, and biological characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect Immun (1992) 2.07
Jejunal bacteriology and bile-salt metabolism in patients with intestinal malabsorption. Lancet (1966) 2.03
Analysis of the Streptococcus downei gtfS gene, which specifies a glucosyltransferase that synthesizes soluble glucans. Infect Immun (1990) 2.00
Glucan-binding proteins of Streptococcus mutans serotype c. J Gen Microbiol (1979) 1.97
Expression of a gene for glucan-binding protein from Streptococcus mutans in Escherichia coli. J Gen Microbiol (1985) 1.93
Immunoblot analysis of the serological response in systemic candidosis. Lancet (1984) 1.90
Isolation of Clostridium difficile from patients and the environment of hospital wards. J Clin Pathol (1983) 1.89
Cloning and expression of two Streptococcus mutans glucosyltransferases in Escherichia coli K-12. Infect Immun (1985) 1.88
Immunisation of monkeys (Macaca fascicularis) with antigens purified from Streptococcus mutans. Br Dent J (1982) 1.81
10 Years of infective endocarditis at St. Bartholomew's Hospital: analysis of clinical features and treatment in relation to prognosis and mortality. Lancet (1980) 1.78
Effect of AMPK activation on muscle glucose metabolism in conscious rats. Am J Physiol (1999) 1.75
Bacteria, bile, and the small bowel. Gut (1969) 1.74
Immunoblotting to demonstrate antigenic and immunogenic differences among nine standard strains of Clostridium difficile. J Clin Microbiol (1986) 1.73
Escherichia coli antibodies in patients with inflammatory bowel disease. Gut (1978) 1.73
Incorporation of bacterial inhibitor into resin composite. J Dent Res (1994) 1.65
Sequence analysis of the wall-associated protein precursor of Streptococcus mutans antigen A. Mol Microbiol (1989) 1.64
One-minute endoscopy room test for Campylobacter pylori. Lancet (1988) 1.64
Method for the typing of Clostridium difficile based on polyacrylamide gel electrophoresis of [35S]methionine-labeled proteins. J Clin Microbiol (1986) 1.64
Isolation of immunodominant antigens from sera of patients with systemic candidiasis and characterization of serological response to Candida albicans. J Clin Microbiol (1987) 1.58
Genetic analysis of a tetracycline resistance element from Clostridium difficile and its conjugal transfer to and from Bacillus subtilis. J Gen Microbiol (1990) 1.57
Identification of a homolog of CcpA catabolite repressor protein in Streptococcus mutans. Infect Immun (1998) 1.57
Mutants of Escherichia coli unable to make protein at 42 C. J Bacteriol (1971) 1.50
A group II intron in a conjugative transposon from the gram-positive bacterium, Clostridium difficile. Gene (1996) 1.47
Distribution of cross-reactive antigens A and B in Streptococcus mutans and other oral streptococci. J Gen Microbiol (1980) 1.47
Two-dimensional SDS-polyacrylamide gel electrophoresis of heat-modifiable outer-membrane proteins. Can J Microbiol (1976) 1.47
Campylobacter species in male homosexuals. Br J Vener Dis (1979) 1.45
The isolation of characterization of Streptococcus mutans serotype h from dental plaque of monkeys (Macaca fascicularis). J Gen Microbiol (1981) 1.44
The clinical importance of gram-positive anaerobic cocci isolated at St Bartholomew's Hospital, London, in 1987. J Med Microbiol (1994) 1.44
Characterization of a plasmid from Helicobacter pylori encoding a replication protein common to plasmids in gram-positive bacteria. Mol Microbiol (1991) 1.43
Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans. J Am Coll Nutr (1995) 1.42
Chryseobacterium (Flavobacterium) meningosepticum outbreak associated with colonization of water taps in a neonatal intensive care unit. J Hosp Infect (2001) 1.42
Use of triton X-100 to overcome the inhibition of fructosyltransferase by SDS. Anal Biochem (1979) 1.41
A selective enrichment broth for the isolation of Clostridium difficile. J Clin Pathol (1984) 1.41
Relationship of toxin production to species in the genus Aeromonas. J Med Microbiol (1986) 1.41
Association between production of toxins A and B and types of Clostridium difficile. J Clin Pathol (1987) 1.38
Glycosyltransferases of Streptococcus mutans strain Ingbritt. Microbios (1978) 1.37
Preliminary findings of the international typing study on Clostridium difficile. International Clostridium Difficile Study Group. Clin Infect Dis (1997) 1.37
The pathophysiological role of small intestinal bacterial flora. Scand J Gastroenterol Suppl (1970) 1.35
Incorporation of antibacterial monomer MDPB into dentin primer. J Dent Res (1997) 1.34
Restriction endonuclease DNA analysis of Clostridium difficile. J Clin Microbiol (1987) 1.33
Temperature-sensitive osmotic remedial mutants of Escherichia coli. J Bacteriol (1972) 1.32
Fructosyltransferase activity of a glucan-binding protein from Streptococcus mutans. J Gen Microbiol (1983) 1.30
Serum-bile-acids in the stagnant-loop syndrome. Lancet (1969) 1.30
Rapid diagnosis of Bacteroides infections by indirect immunofluorescence assay of clinical specimens. Lancet (1979) 1.29
Effect of specific antisera on adherence properties of the oral bacterium Streptococcus mutans. Arch Oral Biol (1982) 1.29
Toxin production by Aeromonas spp. from different sources. J Med Microbiol (1986) 1.28
Rapid fingerprinting of Helicobacter pylori by polymerase chain reaction and restriction fragment length polymorphism analysis. J Clin Microbiol (1993) 1.26
Conditional mutations affecting the cell envelope of Escherichia coli K-12. Genet Res (1973) 1.23
Molecular cloning and expression of Clostridium difficile toxin A in Escherichia coli K12. FEBS Lett (1987) 1.22
Detection and identification of Helicobacter pylori by the polymerase chain reaction. J Clin Pathol (1991) 1.22
HtrA protease and processing of extracellular proteins of Streptococcus mutans. FEMS Microbiol Lett (2001) 1.21
Transport of sugars, including sucrose, by the msm transport system of Streptococcus mutans. J Dent Res (1993) 1.21
Transfer of macrolide-lincosamide-streptogramin B (MLS) resistance in Clostridium difficile is linked to a gene homologous with toxin A and is mediated by a conjugative transposon, Tn5398. J Antimicrob Chemother (1995) 1.21
Mapping of a D-cycloserine resistance locus in escherichia coli K-12. J Bacteriol (1972) 1.19
Biochemical and genetic analysis of Streptococcus mutans alpha-galactosidase. J Gen Microbiol (1991) 1.19
Clostridium difficile and cytotoxin in routine faecal specimens. J Clin Pathol (1982) 1.19
Organization and nucleotide sequence of the Streptococcus mutans galactose operon. Gene (1996) 1.19
SDS-polyacrylamide gel electrophoresis of lipopolysaccharides. Can J Microbiol (1975) 1.18
MsmE, a lipoprotein involved in sugar transport in Streptococcus mutans. J Bacteriol (1993) 1.18
Antigenic and structural analysis of Treponema denticola. J Gen Microbiol (1989) 1.17
Determination of individual bile acids in biological fluids by thin-layer chromatography and fluorimetry. J Clin Pathol (1970) 1.17
Evaluation of a commercial latex particle agglutination test for rapid diagnosis of Haemophilus influenzae type b infection. Pediatrics (1982) 1.16
Mutations affecting amino sugar metabolism in Escherichia coli K-12. J Bacteriol (1972) 1.16
Serological studies of Bacteroides fragilis. J Hyg (Lond) (1977) 1.15
Rapid identification of toxigenic Clostridium difficile by polymerase chain reaction. Lancet (1990) 1.15
Prediction of abuse liability of drugs using IV self-administration by rats. Psychopharmacology (Berl) (1984) 1.15
Molecular cloning and genetic analysis of a chloramphenicol acetyltransferase determinant from Clostridium difficile. Antimicrob Agents Chemother (1988) 1.14
Isolation and characterization of a plasmid from Treponema denticola. FEMS Microbiol Lett (1991) 1.12
Immunoblot analysis of serological responses in invasive aspergillosis. J Clin Pathol (1985) 1.12
A simple biochemical scheme for the differentiation of Streptococcus mutans and Streptococcus sobrinus. Caries Res (1991) 1.11
Mucosal-associated bacterial flora of the intestine in patients with Crohn's disease and in a control group. Gut (1978) 1.11
New suppresor in Escherichia coli. J Bacteriol (1971) 1.11
Tonsil surface and core cultures in recurrent tonsillitis: prevalence of anaerobes and beta-lactamase producing organisms. Eur J Clin Microbiol Infect Dis (1994) 1.11
Relationship of the intestinal bacterial flora to absorption. Br Med Bull (1967) 1.10
Use of immunoblotting to identify antigenic differences between the yeast and mycelial phases of Candida albicans. J Clin Pathol (1985) 1.10
Immunisation against dental caries: further studies. Br Dent J (1979) 1.10
Antibacterial activity of MDPB polymer incorporated in dental resin. J Dent (1995) 1.10
Bactericidal activity and cytotoxicity of antibacterial monomer MDPB. Biomaterials (1999) 1.08
Location of repeat elements in glucansucrases of Leuconostoc and Streptococcus species. FEMS Microbiol Lett (2000) 1.08
New method for typing coagulase negative staphylococci. J Clin Pathol (1986) 1.08
The adsorption of human salivary components to strains of the bacterium Streptococcus mutans. Arch Oral Biol (1984) 1.08
Outbreak of infection in a urological ward. Br Med J (1980) 1.07
Quantitative methods for studies on vaginal flora. J Med Microbiol (1982) 1.06
Effect of the inhibition of protein synthesis on the Escherichia coli cell envelope. Antimicrob Agents Chemother (1974) 1.05